Indeed, according to Matthew Durdy, CEO of Cell and Gene Therapy Catapult, the sector saw an acute period of widespread material shortages as ...
https://www.google.com/url?rct=j&sa=t&url=https://www.pharmaceutical-technology.com/features/a-perfect-storm-covid-19-viral-vector-manufacturing-adds-further-burden-to-car-t-development/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHMjQwTWSuBa-uGVPC_qTijpyDDEA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.